Loading...
XSWX
GALE
Market cap5.70bUSD
Dec 04, Last price  
92.00CHF
1D
0.27%
1Q
4.49%
IPO
113.95%
Name

Galenica AG

Chart & Performance

D1W1MN
XSWX:GALE chart
P/E
25.06
P/S
1.17
EPS
3.67
Div Yield, %
2.39%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
3.47%
Revenues
3.92b
+4.67%
2,826,272,0002,914,917,0003,008,851,0003,145,400,0003,171,342,0003,306,237,0003,479,753,0003,834,679,0004,014,348,0003,746,011,0003,921,081,000
Net income
183m
+5.39%
81,824,00081,122,00083,393,000118,804,000147,546,000124,992,000172,245,000167,680,000165,132,000173,598,000182,951,000
CFO
265m
+17.28%
84,118,000132,435,000156,818,000144,399,000173,550,000250,438,000224,360,000333,095,000236,873,000225,710,000264,703,000
Dividend
Apr 12, 20242.2 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
IPO date
Apr 07, 2017
Employees
7,673
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT